Immune Function Study for Type 1 Diabetes
Immune Function and the Progression to T1D
- Age
- 0 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,800 (estimated)
- Sponsor
- University of Florida · Other
This trial is looking for people who can have their blood drawn to help researchers understand the immune system's role in type 1 diabetes. Participants will provide blood samples and contribute to studying the genetics behind this condition.
You may be able to join if
- I can have my blood drawn
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityTo elucidate the mechanisms by which type 1 diabetes-associated genes; IFIH1, TYK2, IKZF4, as well as total genetic risk, impart functional immunoregulatory abnormalities that result in expansion of self-reactive adaptive immune cells, defective regulatory/effector mechanisms in T cells, inflammatory antigen presenting cells, and abnormal immune function in T cells and B cells.
Loading trial locations…